Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes

Ribi, Karin; Bernhard, Jürg; Schuller, Jan C; Weder, Walter; Bodis, Stephan; Jörger, Markus; Betticher, Daniel; Schmid, Ralph A; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung cancer, 61(3), pp. 398-404. Amsterdam: Elsevier 10.1016/j.lungcan.2008.01.013

Full text not available from this repository.

In patients with malignant pleural mesothelioma undergoing a multimodality therapy, treatment toxicity may outweigh the benefit of progression-free survival. The subjective experience across different treatment phases is an important clinical outcome. This study compares a standard with an individual quality of life (QoL) measure used in a multi-center phase II trial.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Thoracic Surgery
UniBE Contributor:	Bernhard, Jürg Theodor, Schmid, Ralph
ISSN:	0169-5002
ISBN:	18433927
Publisher:	Elsevier
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 15:05
Last Modified:	02 Mar 2023 23:22
Publisher DOI:	10.1016/j.lungcan.2008.01.013
PubMed ID:	18433927
Web of Science ID:	000259800600016
URI:	https://boris.unibe.ch/id/eprint/28182 (FactScience: 118353)